$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/44
출원번호 US-0277633 (1981-06-26)
발명자 / 주소
  • Shen Wei C. (145 Richdale Rd. Needham MA 02194) Ryser Hugues J. (503 Annursnac Hill Rd. Concord MA 01742)
인용정보 피인용 횟수 : 35  인용 특허 : 16

초록

A method for controlling the release of drugs or other passenger moleculars from carrier conjugates, and a class of conjugates that releases drugs when ingested by a cell or subjected to acidic conditions, are disclosed. These conjugates contain a passenger molecule which is attached to a spacer mol

대표청구항

A method of employing a first molecule and a second molecule to transport a third molecule through a first region to a second region that is more acidic than said first region, and to release said third molecule from said first and second molecules in said second region, comprising the following ste

이 특허에 인용된 특허 (16)

  1. Carrico Robert J. (Elkhart IN) Ngo That T. (Elkhart IN), b 상세보기
  • Mune Isao (Osaka JPX) Ushiyama Keiichi (Osaka JPX) Saito Kenitiro (Osaka JPX) Moroishi Yutaka (Osaka JPX) Nakao Tadaichi (Osaka JPX), Antibacterial and antifungal material.
  • Likhite Vilas V. (317 Marlborough St. Boston MA 02116), Antigens comprising immunostimulant adjuvants and their use in immunotherapy.
  • Heller Jorge (Palo Alto CA), Controlled drug release composition.
  • Wright John J. (Cedar Grove NJ), Derivatives of polyene macrolide antibiotics containing an amino sugar moiety, process for the preparation thereof, and.
  • Zweig Jack (145 Vaneck Dr. New Rochelle NY 10804) McLaughlin William (3901 Albemarle St. ; NW. Washington DC 20016) Herz Matthew L. (20 Swanson Rd. Framingham MA 01701), Drug activation by radiation.
  • Carrico Robert J. (Elkhart IN) Ngo That T. (Elkhart IN), Flavin adenine dinucleotide-labeled protein and polypeptide conjugates.
  • Lemieux Raymond U. (Edmonton CAX) Bundle David R. (Ottawa CAX) Baker Donald A. (Edmonton CAX), Glycoside-ether-ester compounds.
  • Sela ; Michael ; Arnon ; Ruth ; Maron ; Ruth ; Hurvitz ; Esther, Immunologic chemotherapeutic agents comprising antigen binding dimers covalently bound to drugs.
  • Rowland George Ferdinand (Gerrards Cross EN), Immunological materials.
  • Goldstein Leon (Rehovot ILX) Freeman Amihay (Rishon Lezion ILX) Sokolovsky Mordechai (Tel-Aviv ILX), Isonitrile derivatives of macromolecules containing hydroxyl groups.
  • De Barbieri Augusto (Milan ITX), N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity.
  • Levin Yehuda (Tel Aviv ILX) Sela Ben-Ami (Rehovot ILX), Novel derivatives of daunomycin.
  • Ross Walter C. J. (Sunbury on Thames GB2), Peptide macromolecular complexes.
  • Wise Donald L. (Belmont MA), Sustained release of pharmaceuticals from polyester matrices.
  • Buckler Robert T. (Edwardsburg MI) Burd John F. (Elkhart IN) Wong Raphael C. (Elkhart IN), Valproic acid immunogen conjugates and antibodies thereto.
  • 이 특허를 인용한 특허 (35)

    1. Barton Russell L. (Indianapolis IN), Antibody-drug conjugates.
    2. Davis, Mark E.; Alabi, Akinleye, Carrier nanoparticles and related compositions, methods and systems.
    3. Davis, Mark E.; Alabi, Akinleye, Carrier nanoparticles and related compositions, methods and systems.
    4. Davis, Mark E.; Alabi, Akinleye, Carrier nanoparticles and related compositions, methods and systems.
    5. Davis, Mark E.; Alabi, Akinleye, Carrier nanoparticles and related compositions, methods and systems.
    6. Davis, Mark E.; Alabi, Akinleye, Carrier nanoparticles and related compositions, methods and systems.
    7. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
    8. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
    9. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
    10. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into epithelial tissues.
    11. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, Leo P.; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into ocular tissues.
    12. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for enhancing drug delivery across and into ocular tissues.
    13. Rothbard,Jonathan B.; Wender,Paul A.; McGrane,P. Leo; Sista,Lalitha V. S.; Kirschberg,Thorsten A., Compositions and methods for enhancing drug delivery across and into ocular tissues.
    14. Bond, Vincent C.; Lillard, Jr., James W.; Huang, Ming Bo, Compositions and methods for treating diseases by inhibiting exosome release.
    15. Rothbard, Jonathan B.; Wender, Paul A.; McGrane, P. Leo; Sista, Lalitha V. S.; Kirschberg, Thorsten A., Compositions and methods for treating inflammatory diseases of the skin.
    16. De Souza Russo,Elisa Mannochio; Torres Russo,Valter Freire, Compounds in the form of homodimeric or heterodimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodieste.
    17. Green, Howard; Compton, Bruce; Corey, George; Djian, Philippe, Conjugates of agents and transglutaminase substrate linking molecules.
    18. Santi, Daniel V.; Hearn, Brian, Conjugates with reduced adverse systemic effects.
    19. Johnson David A. (Carmel IN) Laguzza Bennett C. (Indianapolis IN) Scott William L. (Indianapolis IN), Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers.
    20. Cullinan George J. (Trafalgar IN) Laguzza Bennett C. (Indianapolis IN) Scott William L. (Indianapolis IN), Intermediates for antibody-vinca drug conjugates.
    21. Green, Howard; Compton, Bruce J.; Corey, George D.; Djian, Philippe, Linkage of agents to body tissue using microparticles and transglutaminase.
    22. Jonathan B. Rothbard ; Paul A. Wender, Method and composition for enhancing transport across biological membranes.
    23. Rothbard Jonathan B. ; Wender Paul A., Method and composition for enhancing transport across biological membranes.
    24. Wiley, Devin; Clark, Andrew; Davis, Mark E., Method of delivering therapeutics and imaging agents to the brain by nanoparticles that cross the blood brain barrier.
    25. McChesney, James D.; Chander, Madhavi C.; Siahaan, Teruna J.; Xu, Christine R.; Ainsworth, Sterling K., Molecular conjugates for use in treatment of cancer.
    26. McChesney,James D.; Chander,Madhavi C.; Siahaan,Teruna J.; Xu,Christine R.; Ainsworth,Sterling K., Molecular conjugates for use in treatment of cancer.
    27. Renslo, Adam; Mahajan, Sumit, Prodrug compositions and methods for using the same in treating cancer and malaria.
    28. Shen, Wei-Chiang; Heiati, Hashem, Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use.
    29. Davis, Mark E.; Han, Han, Targeted nanoparticles.
    30. Friden Phillip M., Transferrin receptor reactive chimeric antibodies.
    31. Friden Phillip M., Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates.
    32. Friden Phillip M., Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates.
    33. Friden Phillip M. ; Starzyk Ruth M. ; Morrison Sherie L. ; Park Eun-Chung ; McGrath John P., Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins.
    34. Bredesen, Dale E.; Galvan, Veronica, Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664.
    35. Hellstrom Karl E. (Seattle WA) Hellstrom Ingegerd E. (Seattle WA) Lavie Efraim (Seattle WA), pH-sensitive immunoconjugates and methods for their use in tumor therapy.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로